Hughes and Associates

12/30/2025

For many Clinical Pharmacology leaders, the holiday period brings quieter calendars and fewer meetings.

December isn’t a pause; it’s a planning window.

With fewer interruptions and lighter schedules, this time of year often creates the space for clearer thinking, more thoughtful discussions, and future-focused decisions that can be difficult to make during busier program cycles.

12/23/2025

Season’s Greetings from Hughes and Associates!

As we close the year, we look ahead to 2026 with focus and purpose. We’re grateful to the leaders, partners, and candidates who trusted us with critical hiring decisions across the pharmaceutical and biotechnology industries.

Wishing you a peaceful holiday season and a successful year ahead.

12/18/2025

The holidays are often viewed as a slow or impractical time to recruit.

In reality, December through early January can be one of the most effective windows to quietly secure hard-to-fill leadership and senior technical talent, particularly in Clinical Pharmacology, PK/PD (DMPK/PKPD), and MIDD, while the market is distracted and competition is paused.

In our latest blog, we share 5 Holiday Hiring Hacks biotech and pharmaceutical teams are using to get ahead of 2026 planning, without job postings, noise, or wasted time.

👉 Read the full article: https://www.haallc.com/2025/12/17/holiday-hiring-in-clinical-pharmacology/

If a quiet, confidential conversation would be helpful, feel free to message us.

Discover the advantages of holiday hiring in clinical pharmacology. Now is the perfect time to secure exceptional candidates.

12/12/2025

In today’s data-driven biotech landscape, competitive advantage comes from how well your quantitative teams are integrated.

Future-ready organizations align Clinical Pharmacology, Pharmacometrics, QSP, DMPK, and Bioanalysis, and empower scientists to influence decisions across development.

The result? Faster programs, clearer strategy, and reduced risk.

At Hughes & Associates, we partner with biotech and pharma companies to build high-impact quantitative science teams, one strategic hire at a time.

Let’s build the team your pipeline needs next.
📩jchapman@haallc.com
📞 704-264-5203

12/04/2025

🎙️ New Podcast Alert!
Give this a listen and stay ahead of the evolving 2025–2026 talent landscape in Modeling & Simulation.

Demand for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology talent is outpacing supply. As 2026 approaches, hybrid scientists and strong communicators will be among the most sought-after profiles in biopharma.

🔥 Key takeaways:
• Hybrid M&S scientists are becoming the gold standard
• Demand will continue to outpace supply in 2026
• Communication and cross-functional influence matter more than ever
• Market shifts are creating new mobility and career advantages

If you’re planning your next move or exploring the 2026 landscape, we can help you navigate the opportunities ahead.

👉 Ready to take the next step? Contact us directly at www.haallc.com

12/02/2025

Model-informed drug development is evolving fast, and for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology professionals, 2026 will be a pivotal year.

The industry is moving toward hybrid scientists who can bridge computation, biology, and strategic decision-making. With the demand accelerating faster than the talent pool, top modeling & simulation experts are entering 2026 with unprecedented leverage.

Our latest newsletter highlights:
✅ Why hybrid profiles are becoming the new standard
✅ How demand for M&S talent will outpace supply even further in 2026
✅ The rising importance of communication and cross-functional impact
✅ New mobility created by retention challenges
✅ How to position your CV and career direction now for 2025–2026

👉 If you're exploring new opportunities or simply assessing your market position, this is the moment to prepare.

At Hughes & Associates, we support professionals across biotech and pharma, helping them translate scientific impact into strategic career growth.

🔗 Read the full feature and plan your 2025–2026 career strategy: https://www.haallc.com/2025/11/27/career-opportunities-in-2025-2026-positioning-yourself-for-model-informed-roles/

Uncover the trends in Model-Informed Drug Development and the growing demand for modeling and simulation experts in biopharma.

11/19/2025

AI is accelerating change across life sciences in 2025, from personalized dosing to real-time modeling, advanced ADME predictions, and faster biomarker validation. These innovations are reshaping Clinical Pharmacology, Pharmacometrics, DMPK, QSP, and Bioanalysis, and driving demand for specialists who can integrate AI into scientific decision-making.

At Hughes and Associates, we help organizations find the cross-disciplinary experts who can bridge domain knowledge with AI-driven modeling and analysis.

💬Which AI-related skill is hardest for your team to hire for today?

11/14/2025

🎙️ New Podcast Episode: Hiring Challenges & Opportunities in 2025
Model-informed talent is reshaping drug development, and the competition for experts has never been sharper. From QSP to Pharmacometrics, Clinical Pharmacology, and DMPK, organizations are racing to secure the scientists who drive smarter decisions and stronger R&D outcomes.

🎧 Listen in: We break down the rise of hybrid scientists, why demand is outpacing supply, and what companies must do to build model-informed teams that can lead in 2025.

📺 Watch the full episode on YouTube and subscribe for more insights in quantitative drug development: https://lnkd.in/gCKiudg4

Thinking about strengthening your team or exploring new opportunities?
Schedule a complimentary call with our SVP, Jay Chapman
jchapman@haallc.com📞 704-264-5203

11/12/2025

The race for drug development talent is accelerating. Are you keeping pace?

In 2025, breakthroughs in biologics, gene therapies, mRNA vaccines, and rare disease research are transforming biopharma. But one reality remains:

💡 Science is advancing faster than the talent market.

Biotech and pharma companies are competing for a small pool of experts in QSP, Pharmacometrics, DMPK, and Clinical Pharmacology, professionals who not only model data but shape strategy and regulatory success.

Our latest newsletter explores:
✅ The rise of hybrid scientists bridging biology and computation
✅ How demand for modeling talent is outpacing supply
✅ The growing importance of collaboration and retention
✅ Why model-informed hiring is now a strategic imperative

👉 If your 2025 R&D goals depend on modeling and simulation, now is the time to act.
Traditional recruiting won’t secure the expertise you need, precision hiring will.

At Hughes & Associates, we specialize exclusively in building model-informed teams across biotech and pharma.
From Clinical Pharmacology to QSP, Pharmacometrics, and DMPK, we deliver the scientists who turn data into decisions.

Let’s build your next competitive advantage.
Contact Jay Chapman:
📧jchapman@haallc.com
📞704-264-5203

🔗 Read the full feature and discover how strategic recruitment drives innovation: https://hubs.ly/Q03SBVKt0

Explore how drug development is shaping the biopharma landscape in 2025, highlighting the need for specialized talent.

11/05/2025

Behind every successful IND or NDA is a clinical pharmacology team making critical dose, safety, and modeling decisions that define success.

💡Did you know:
• Up to 50% of a drug’s label is clinical pharmacology data.
• The FDA’s Model-Informed Drug Development (MIDD) approach is reshaping early development.
• The right clinical pharmacologist can de-risk millions in R&D investment.

At Hughes and Associates, we help life-science firms hire leaders who combine scientific rigor with strategic vision.

💬 What’s your biggest challenge in finding or retaining top clinical pharmacology talent?

Let’s talk strategy.
📩 jchapman@haallc.com
📞704-264-5203

10/24/2025

The Demand for DMPK Scientists: 2025 Career Insights

DMPK experts are shaping the future of drug development, and companies are hiring. We cover why demand is rising, where opportunities are growing, and how to take your next step.

Watch the full episode on YouTube and follow our page for new roles & tips: https://youtu.be/DV50QJgOY0Q

Want to discuss your next move?

Get in touch:
📩 https://www.haallc.com/contact-us/

10/23/2025

We’re proud of our SVP, Jay Chapman, for representing Hughes and Associates as a panelist at the recent American Society for Clinical Pharmacology & Therapeutics - ASCPT Career Connect event. 👏

The session, “Navigating the Evolving Landscape of Clinical Pharmacology: Strategies for Leadership, Innovation, and Impact in Drug Development”, brought together thought leaders to share forward-looking perspectives on innovation, leadership, and the future of drug development.

It’s inspiring to see such meaningful discussions shaping the next generation of scientific and strategic leadership within clinical pharmacology.

We look forward to continuing the conversation on advancing talent, innovation, and leadership across the life sciences.

Ready to elevate your career in clinical pharmacology? Join our expert-led webinar on leadership, innovation, and impact in drug development - Thursday, October 23 at 12 pm ET. Register today: https://bit.ly/4onMPaK